510(k) Report

510(k) · Cleared

Cleared

Poseidon OCT Spinal Fixation System

K161637510(k) TraditionalCleared Jan 5, 2017205-day reviewClass II21 CFR 888.3075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medyssey USA, Inc. · NKG Posterior Cervical Screw System

Cleared on Jan 5, 2017 as substantially equivalent to K142838 (Synthes USA Products, LLC, 2015) and 1 other predicate after a 205-day review. Its family tree reaches back 3 generations to 1997.

Decided
Jan 5, 2017
Review
205 days
Class
Class II
Product code
NKG
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K953076 (1997). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK953076 Townley Facet/Pedicular Screw Plating SystemSofamor Danek USA,Inc. · 1997
  2. 2 generations backK062254 Axis Fixation SystemMedtronic Sofamor Danek, Inc. · 2008
  3. 1 generation backK142838 Synapse Occipital-Cervical-Thoracic (OCT) SystemSynthes USA Products, LLC · 2015 · Recalled
  4. This deviceK161637 Poseidon OCT Spinal Fixation SystemMedyssey USA, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K953076Townley Facet/Pedicular Screw Plating SystemSofamor Danek USA,Inc.1997—
−2K062254Axis Fixation SystemMedtronic Sofamor Danek, Inc.2008—
−1K142838Synapse Occipital-Cervical-Thoracic (OCT) SystemSynthes USA Products, LLC20151
0 (this device)K161637Poseidon OCT Spinal Fixation SystemMedyssey USA, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
201510
FIG. 1 — Lineage of K161637, 1997–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NKG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NKG device

  1. #1 K252327 CMORE® CT System; CMORE® CT System Navigated…score 19.6 · 22 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142838Synapse Occipital-Cervical-Thoracic (OCT) System
Summary page 4
…es these devices are substantially equivalent to a predicate device previously cleared by FDA. The primary predicate device is the Synapse OCT System from DePuy/Synthes (K142838). One additional predicate device is the Vertex Reconstruction System from Medtronic (K143471). Performance Standards: The pre-c…
Synthes USA Products, LLC20151
*K143471VERTEX Reconstruction System
Summary page 4
…The primary predicate device is the Synapse OCT System from DePuy/Synthes (K142838). One additional predicate device is the Vertex Reconstruction System from Medtronic (K143471). Performance Standards: The pre-clinical testing was conducted per ASTM F2706 and ASTM F1798. Testing included: • Static an…
Medtronic Sofamor Danek USA, Inc.2015—

Also cleared against K142838: 31 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 6.6 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • 31 other devices also cite its predicate K142838.

How does its category compare?

All NKG devices

NKG Posterior Cervical Screw System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · NKG

6in 2025

2015: 172016: 162017: 152018: 122019: 82020: 142021: 72022: 72023: 102024: 32025: 62026 (partial year): 4
2007high 17 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NKG

58in 2025

2015: 71 days median2016: 87 days median2017: 108 days median2018: 61 days median2019: 50 days median2020: 59 days median2021: 56 days median2022: 108 days median2023: 58 days median2024: 100 days median2025: 58 days median2026 (partial year): 169 days median
2007high 169 (2026) · low 50 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NKG

2in 2020

2018: 12019: 12020: 2
2007high 2 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NKG

153in 2025

2015: 42016: 732017: 992018: 1272019: 2142020: 2362021: 7042022: 1752023: 1312024: 2062025: 153
2007high 704 (2021) · low 0 (2007)2025

MAUDE reports naming product code NKG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
2015177104
20161687073
201715108099
201812611127
20198501214
202014592236
20217560704
202271080175
202310580131
202431000206
20256580153
202641690—

What is it indicated for?

The Poseidon OCT Spinal Fixation System is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1 to T3): traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudoarthrosis); tumors involving the cervical/thoracic…

Read the full statement (175 words)

The Poseidon OCT Spinal Fixation System is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1 to T3): traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudoarthrosis); tumors involving the cervical/thoracic spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability.

The Poseidon OCT Spinal Fixation System is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.

In order to achieve additional levels of fixation, the Poseidon OCT Spinal Fixation System may be connected to the Medyssey Zenius, Iliad or Kora Spinal Systems using parallel connectors and taper rods.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161637: Poseidon OCT Spinal Fixation System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161637

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026